nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—VRK2—schizophrenia	0.29	0.417	CbGaD
Bosutinib—FES—schizophrenia	0.22	0.316	CbGaD
Bosutinib—ERBB4—schizophrenia	0.0983	0.141	CbGaD
Bosutinib—ERBB3—schizophrenia	0.0766	0.11	CbGaD
Bosutinib—ABCB1—schizophrenia	0.0104	0.015	CbGaD
Bosutinib—Vandetanib—ERBB3—schizophrenia	0.00133	0.442	CrCbGaD
Bosutinib—Gefitinib—ERBB3—schizophrenia	0.00126	0.42	CrCbGaD
Bosutinib—Gefitinib—CYP2D6—schizophrenia	0.000241	0.0802	CrCbGaD
Bosutinib—Gefitinib—ABCB1—schizophrenia	0.000172	0.0573	CrCbGaD
Bosutinib—BCR—central nervous system—schizophrenia	0.000147	0.00117	CbGeAlD
Bosutinib—CSNK1A1—nervous system—schizophrenia	0.000146	0.00116	CbGeAlD
Bosutinib—MAP3K12—central nervous system—schizophrenia	0.000146	0.00116	CbGeAlD
Bosutinib—HCK—nervous system—schizophrenia	0.000145	0.00116	CbGeAlD
Bosutinib—CLK1—nervous system—schizophrenia	0.000145	0.00116	CbGeAlD
Bosutinib—CSNK1E—endocrine gland—schizophrenia	0.000145	0.00115	CbGeAlD
Bosutinib—MAP4K4—cerebellum—schizophrenia	0.000145	0.00115	CbGeAlD
Bosutinib—YES1—gonad—schizophrenia	0.000144	0.00115	CbGeAlD
Bosutinib—STK4—brain—schizophrenia	0.000144	0.00114	CbGeAlD
Bosutinib—BCR—cerebellum—schizophrenia	0.000144	0.00114	CbGeAlD
Bosutinib—NUAK2—cerebellum—schizophrenia	0.000144	0.00114	CbGeAlD
Bosutinib—SLK—blood—schizophrenia	0.000143	0.00114	CbGeAlD
Bosutinib—STK10—gonad—schizophrenia	0.000143	0.00114	CbGeAlD
Bosutinib—MAP2K1—central nervous system—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—STK35—central nervous system—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—BMP2K—nervous system—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—CAMK2G—nervous system—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—SIK1—endocrine gland—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—MAP3K12—cerebellum—schizophrenia	0.000143	0.00113	CbGeAlD
Bosutinib—EPHB4—blood—schizophrenia	0.000142	0.00113	CbGeAlD
Bosutinib—CAMK1D—brain—schizophrenia	0.000142	0.00113	CbGeAlD
Bosutinib—CSK—central nervous system—schizophrenia	0.000142	0.00113	CbGeAlD
Bosutinib—SLK—midbrain—schizophrenia	0.000142	0.00113	CbGeAlD
Bosutinib—LRRK2—nervous system—schizophrenia	0.000142	0.00112	CbGeAlD
Bosutinib—EPHA4—endocrine gland—schizophrenia	0.000141	0.00112	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—schizophrenia	0.000141	0.00112	CbGeAlD
Bosutinib—STK24—brain—schizophrenia	0.000141	0.00112	CbGeAlD
Bosutinib—EPHB4—midbrain—schizophrenia	0.000141	0.00112	CbGeAlD
Bosutinib—HCK—central nervous system—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—CLK1—central nervous system—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—ERBB3—endocrine gland—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—EPHA2—blood—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—MAP2K1—cerebellum—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—STK35—cerebellum—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—MAP2K2—endocrine gland—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—ULK3—endocrine gland—schizophrenia	0.00014	0.00111	CbGeAlD
Bosutinib—FYN—blood—schizophrenia	0.000139	0.00111	CbGeAlD
Bosutinib—SRC—gonad—schizophrenia	0.000139	0.0011	CbGeAlD
Bosutinib—CSK—cerebellum—schizophrenia	0.000139	0.0011	CbGeAlD
Bosutinib—MAP3K2—endocrine gland—schizophrenia	0.000139	0.0011	CbGeAlD
Bosutinib—PTK2B—nervous system—schizophrenia	0.000138	0.0011	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—schizophrenia	0.000138	0.00109	CbGeAlD
Bosutinib—FYN—midbrain—schizophrenia	0.000138	0.00109	CbGeAlD
Bosutinib—CAMK2G—central nervous system—schizophrenia	0.000137	0.00109	CbGeAlD
Bosutinib—BMP2K—central nervous system—schizophrenia	0.000137	0.00109	CbGeAlD
Bosutinib—CLK1—cerebellum—schizophrenia	0.000137	0.00109	CbGeAlD
Bosutinib—LRRK2—central nervous system—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—MAP3K3—blood—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—MAP4K5—blood—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—TYRO3—brain—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—FER—brain—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—EPHA5—brain—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—ALK—brain—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—ABL2—cerebellum—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—CSNK1E—nervous system—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—PTK2—endocrine gland—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—TBK1—endocrine gland—schizophrenia	0.000136	0.00108	CbGeAlD
Bosutinib—LYN—brain—schizophrenia	0.000135	0.00108	CbGeAlD
Bosutinib—MAP3K3—midbrain—schizophrenia	0.000135	0.00107	CbGeAlD
Bosutinib—MAP4K5—midbrain—schizophrenia	0.000135	0.00107	CbGeAlD
Bosutinib—BMP2K—cerebellum—schizophrenia	0.000134	0.00107	CbGeAlD
Bosutinib—CAMK2G—cerebellum—schizophrenia	0.000134	0.00107	CbGeAlD
Bosutinib—SIK1—nervous system—schizophrenia	0.000134	0.00106	CbGeAlD
Bosutinib—IRAK4—nervous system—schizophrenia	0.000134	0.00106	CbGeAlD
Bosutinib—MAP4K1—brain—schizophrenia	0.000133	0.00106	CbGeAlD
Bosutinib—MAP3K19—brain—schizophrenia	0.000133	0.00106	CbGeAlD
Bosutinib—LRRK2—cerebellum—schizophrenia	0.000133	0.00106	CbGeAlD
Bosutinib—EGFR—cerebellum—schizophrenia	0.000133	0.00106	CbGeAlD
Bosutinib—PTK2B—central nervous system—schizophrenia	0.000133	0.00106	CbGeAlD
Bosutinib—BTK—brain—schizophrenia	0.000133	0.00105	CbGeAlD
Bosutinib—PDGFRB—telencephalon—schizophrenia	0.000133	0.00105	CbGeAlD
Bosutinib—EPHA4—nervous system—schizophrenia	0.000132	0.00105	CbGeAlD
Bosutinib—ERBB3—nervous system—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—TNK2—brain—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—CSNK1E—central nervous system—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—ULK3—nervous system—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—MAP2K2—nervous system—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—RPS6KB1—endocrine gland—schizophrenia	0.000131	0.00104	CbGeAlD
Bosutinib—PTK2B—cerebellum—schizophrenia	0.00013	0.00103	CbGeAlD
Bosutinib—FGR—endocrine gland—schizophrenia	0.00013	0.00103	CbGeAlD
Bosutinib—MAP3K2—nervous system—schizophrenia	0.00013	0.00103	CbGeAlD
Bosutinib—AXL—endocrine gland—schizophrenia	0.000129	0.00103	CbGeAlD
Bosutinib—MAP4K2—brain—schizophrenia	0.000129	0.00102	CbGeAlD
Bosutinib—SIK1—central nervous system—schizophrenia	0.000129	0.00102	CbGeAlD
Bosutinib—IRAK4—central nervous system—schizophrenia	0.000129	0.00102	CbGeAlD
Bosutinib—CSNK1E—cerebellum—schizophrenia	0.000128	0.00101	CbGeAlD
Bosutinib—EPHA4—central nervous system—schizophrenia	0.000127	0.00101	CbGeAlD
Bosutinib—ERBB4—brain—schizophrenia	0.000127	0.00101	CbGeAlD
Bosutinib—STK3—brain—schizophrenia	0.000127	0.00101	CbGeAlD
Bosutinib—TBK1—nervous system—schizophrenia	0.000127	0.00101	CbGeAlD
Bosutinib—PTK2—nervous system—schizophrenia	0.000127	0.00101	CbGeAlD
Bosutinib—ERBB3—central nervous system—schizophrenia	0.000126	0.001	CbGeAlD
Bosutinib—YES1—blood—schizophrenia	0.000126	0.001	CbGeAlD
Bosutinib—MAP2K2—central nervous system—schizophrenia	0.000126	0.000999	CbGeAlD
Bosutinib—ULK3—central nervous system—schizophrenia	0.000126	0.000999	CbGeAlD
Bosutinib—SIK1—cerebellum—schizophrenia	0.000126	0.000999	CbGeAlD
Bosutinib—IRAK4—cerebellum—schizophrenia	0.000126	0.000999	CbGeAlD
Bosutinib—ROCK1—brain—schizophrenia	0.000126	0.000998	CbGeAlD
Bosutinib—MAP3K2—central nervous system—schizophrenia	0.000125	0.000992	CbGeAlD
Bosutinib—CSF1R—gonad—schizophrenia	0.000125	0.000991	CbGeAlD
Bosutinib—STK10—blood—schizophrenia	0.000125	0.000991	CbGeAlD
Bosutinib—EPHA4—cerebellum—schizophrenia	0.000124	0.000989	CbGeAlD
Bosutinib—YES1—midbrain—schizophrenia	0.000124	0.000987	CbGeAlD
Bosutinib—TAOK3—blood—schizophrenia	0.000124	0.000987	CbGeAlD
Bosutinib—EPHB4—endocrine gland—schizophrenia	0.000123	0.000981	CbGeAlD
Bosutinib—ERBB3—cerebellum—schizophrenia	0.000123	0.000979	CbGeAlD
Bosutinib—ULK3—cerebellum—schizophrenia	0.000123	0.000977	CbGeAlD
Bosutinib—MAP2K2—cerebellum—schizophrenia	0.000123	0.000977	CbGeAlD
Bosutinib—TAOK3—midbrain—schizophrenia	0.000123	0.000975	CbGeAlD
Bosutinib—TBK1—central nervous system—schizophrenia	0.000122	0.000971	CbGeAlD
Bosutinib—PTK2—central nervous system—schizophrenia	0.000122	0.000971	CbGeAlD
Bosutinib—RPS6KB1—nervous system—schizophrenia	0.000122	0.000971	CbGeAlD
Bosutinib—MAP3K2—cerebellum—schizophrenia	0.000122	0.00097	CbGeAlD
Bosutinib—BMPR2—brain—schizophrenia	0.000122	0.000969	CbGeAlD
Bosutinib—FGR—nervous system—schizophrenia	0.000121	0.000965	CbGeAlD
Bosutinib—EPHA2—endocrine gland—schizophrenia	0.000121	0.000962	CbGeAlD
Bosutinib—SRC—blood—schizophrenia	0.000121	0.000962	CbGeAlD
Bosutinib—EPHB3—brain—schizophrenia	0.000121	0.000961	CbGeAlD
Bosutinib—STK36—brain—schizophrenia	0.000121	0.000961	CbGeAlD
Bosutinib—AXL—nervous system—schizophrenia	0.000121	0.000961	CbGeAlD
Bosutinib—FYN—endocrine gland—schizophrenia	0.000121	0.000961	CbGeAlD
Bosutinib—MAP3K7—cerebellum—schizophrenia	0.000121	0.00096	CbGeAlD
Bosutinib—MERTK—brain—schizophrenia	0.00012	0.00095	CbGeAlD
Bosutinib—TBK1—cerebellum—schizophrenia	0.00012	0.000949	CbGeAlD
Bosutinib—PTK2—cerebellum—schizophrenia	0.00012	0.000949	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—schizophrenia	0.000118	0.000939	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—schizophrenia	0.000118	0.000939	CbGeAlD
Bosutinib—ABL1—telencephalon—schizophrenia	0.000118	0.000939	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—schizophrenia	0.000118	0.000935	CbGeAlD
Bosutinib—MAP4K4—brain—schizophrenia	0.000117	0.000933	CbGeAlD
Bosutinib—IRAK1—cerebellum—schizophrenia	0.000117	0.000931	CbGeAlD
Bosutinib—FGR—central nervous system—schizophrenia	0.000117	0.000929	CbGeAlD
Bosutinib—NUAK2—brain—schizophrenia	0.000117	0.000926	CbGeAlD
Bosutinib—BCR—brain—schizophrenia	0.000117	0.000926	CbGeAlD
Bosutinib—AXL—central nervous system—schizophrenia	0.000116	0.000925	CbGeAlD
Bosutinib—MAP3K12—brain—schizophrenia	0.000116	0.00092	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—schizophrenia	0.000115	0.000913	CbGeAlD
Bosutinib—AXL—cerebellum—schizophrenia	0.000114	0.000904	CbGeAlD
Bosutinib—MAP2K1—brain—schizophrenia	0.000113	0.000901	CbGeAlD
Bosutinib—STK35—brain—schizophrenia	0.000113	0.000901	CbGeAlD
Bosutinib—EPHA2—nervous system—schizophrenia	0.000113	0.000901	CbGeAlD
Bosutinib—FYN—nervous system—schizophrenia	0.000113	0.000899	CbGeAlD
Bosutinib—CSK—brain—schizophrenia	0.000113	0.000895	CbGeAlD
Bosutinib—CSNK1A1—brain—schizophrenia	0.000112	0.000889	CbGeAlD
Bosutinib—MAP2K5—blood—schizophrenia	0.000111	0.000885	CbGeAlD
Bosutinib—CLK1—brain—schizophrenia	0.000111	0.000884	CbGeAlD
Bosutinib—HCK—brain—schizophrenia	0.000111	0.000884	CbGeAlD
Bosutinib—PDGFRB—gonad—schizophrenia	0.000111	0.000879	CbGeAlD
Bosutinib—MAP4K5—nervous system—schizophrenia	0.000111	0.000879	CbGeAlD
Bosutinib—MAP3K3—nervous system—schizophrenia	0.000111	0.000879	CbGeAlD
Bosutinib—ABL2—brain—schizophrenia	0.000111	0.000878	CbGeAlD
Bosutinib—MAP2K5—midbrain—schizophrenia	0.00011	0.000874	CbGeAlD
Bosutinib—SLK—cerebellum—schizophrenia	0.00011	0.00087	CbGeAlD
Bosutinib—EPHA2—central nervous system—schizophrenia	0.000109	0.000867	CbGeAlD
Bosutinib—CAMK2G—brain—schizophrenia	0.000109	0.000867	CbGeAlD
Bosutinib—BMP2K—brain—schizophrenia	0.000109	0.000867	CbGeAlD
Bosutinib—YES1—endocrine gland—schizophrenia	0.000109	0.000867	CbGeAlD
Bosutinib—FYN—central nervous system—schizophrenia	0.000109	0.000866	CbGeAlD
Bosutinib—EPHB4—cerebellum—schizophrenia	0.000109	0.000864	CbGeAlD
Bosutinib—CSF1R—blood—schizophrenia	0.000109	0.000863	CbGeAlD
Bosutinib—LRRK2—brain—schizophrenia	0.000108	0.000859	CbGeAlD
Bosutinib—STK10—endocrine gland—schizophrenia	0.000108	0.000859	CbGeAlD
Bosutinib—EGFR—brain—schizophrenia	0.000108	0.000857	CbGeAlD
Bosutinib—TAOK3—endocrine gland—schizophrenia	0.000108	0.000856	CbGeAlD
Bosutinib—CSF1R—midbrain—schizophrenia	0.000107	0.000853	CbGeAlD
Bosutinib—FYN—cerebellum—schizophrenia	0.000107	0.000846	CbGeAlD
Bosutinib—MAP4K5—central nervous system—schizophrenia	0.000106	0.000846	CbGeAlD
Bosutinib—MAP3K3—central nervous system—schizophrenia	0.000106	0.000846	CbGeAlD
Bosutinib—PTK2B—brain—schizophrenia	0.000105	0.000838	CbGeAlD
Bosutinib—SRC—endocrine gland—schizophrenia	0.000105	0.000834	CbGeAlD
Bosutinib—MAP3K3—cerebellum—schizophrenia	0.000104	0.000827	CbGeAlD
Bosutinib—MAP4K5—cerebellum—schizophrenia	0.000104	0.000827	CbGeAlD
Bosutinib—CSNK1E—brain—schizophrenia	0.000104	0.000824	CbGeAlD
Bosutinib—CYP3A4—blood plasma—schizophrenia	0.000103	0.000818	CbGeAlD
Bosutinib—YES1—nervous system—schizophrenia	0.000102	0.000812	CbGeAlD
Bosutinib—SIK1—brain—schizophrenia	0.000102	0.000811	CbGeAlD
Bosutinib—IRAK4—brain—schizophrenia	0.000102	0.000811	CbGeAlD
Bosutinib—STK10—nervous system—schizophrenia	0.000101	0.000804	CbGeAlD
Bosutinib—EPHA4—brain—schizophrenia	0.000101	0.000803	CbGeAlD
Bosutinib—TAOK3—nervous system—schizophrenia	0.000101	0.000801	CbGeAlD
Bosutinib—ERBB3—brain—schizophrenia	0.0001	0.000795	CbGeAlD
Bosutinib—ULK3—brain—schizophrenia	9.98e-05	0.000793	CbGeAlD
Bosutinib—MAP2K2—brain—schizophrenia	9.98e-05	0.000793	CbGeAlD
Bosutinib—MAP3K2—brain—schizophrenia	9.91e-05	0.000788	CbGeAlD
Bosutinib—ABL1—gonad—schizophrenia	9.86e-05	0.000783	CbGeAlD
Bosutinib—YES1—central nervous system—schizophrenia	9.84e-05	0.000781	CbGeAlD
Bosutinib—SRC—nervous system—schizophrenia	9.83e-05	0.000781	CbGeAlD
Bosutinib—MAP3K7—brain—schizophrenia	9.82e-05	0.00078	CbGeAlD
Bosutinib—STK10—central nervous system—schizophrenia	9.75e-05	0.000774	CbGeAlD
Bosutinib—TAOK3—central nervous system—schizophrenia	9.71e-05	0.000771	CbGeAlD
Bosutinib—PTK2—brain—schizophrenia	9.71e-05	0.000771	CbGeAlD
Bosutinib—TBK1—brain—schizophrenia	9.71e-05	0.000771	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—schizophrenia	9.66e-05	0.000767	CbGeAlD
Bosutinib—PDGFRB—blood—schizophrenia	9.64e-05	0.000766	CbGeAlD
Bosutinib—YES1—cerebellum—schizophrenia	9.61e-05	0.000764	CbGeAlD
Bosutinib—STK10—cerebellum—schizophrenia	9.53e-05	0.000757	CbGeAlD
Bosutinib—PDGFRB—midbrain—schizophrenia	9.52e-05	0.000756	CbGeAlD
Bosutinib—IRAK1—brain—schizophrenia	9.52e-05	0.000756	CbGeAlD
Bosutinib—TAOK3—cerebellum—schizophrenia	9.49e-05	0.000754	CbGeAlD
Bosutinib—SRC—central nervous system—schizophrenia	9.46e-05	0.000752	CbGeAlD
Bosutinib—CSF1R—endocrine gland—schizophrenia	9.43e-05	0.000749	CbGeAlD
Bosutinib—RPS6KB1—brain—schizophrenia	9.34e-05	0.000742	CbGeAlD
Bosutinib—FGR—brain—schizophrenia	9.28e-05	0.000737	CbGeAlD
Bosutinib—SRC—cerebellum—schizophrenia	9.25e-05	0.000735	CbGeAlD
Bosutinib—AXL—brain—schizophrenia	9.24e-05	0.000734	CbGeAlD
Bosutinib—MAP2K5—nervous system—schizophrenia	9.04e-05	0.000718	CbGeAlD
Bosutinib—SLK—brain—schizophrenia	8.9e-05	0.000707	CbGeAlD
Bosutinib—EPHB4—brain—schizophrenia	8.83e-05	0.000702	CbGeAlD
Bosutinib—CSF1R—nervous system—schizophrenia	8.82e-05	0.000701	CbGeAlD
Bosutinib—MAP2K5—central nervous system—schizophrenia	8.7e-05	0.000692	CbGeAlD
Bosutinib—EPHA2—brain—schizophrenia	8.67e-05	0.000689	CbGeAlD
Bosutinib—FYN—brain—schizophrenia	8.65e-05	0.000687	CbGeAlD
Bosutinib—ABL1—blood—schizophrenia	8.59e-05	0.000683	CbGeAlD
Bosutinib—MAP2K5—cerebellum—schizophrenia	8.51e-05	0.000676	CbGeAlD
Bosutinib—CSF1R—central nervous system—schizophrenia	8.49e-05	0.000675	CbGeAlD
Bosutinib—ABL1—midbrain—schizophrenia	8.48e-05	0.000674	CbGeAlD
Bosutinib—MAP4K5—brain—schizophrenia	8.45e-05	0.000672	CbGeAlD
Bosutinib—MAP3K3—brain—schizophrenia	8.45e-05	0.000672	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—schizophrenia	8.36e-05	0.000664	CbGeAlD
Bosutinib—CSF1R—cerebellum—schizophrenia	8.3e-05	0.00066	CbGeAlD
Bosutinib—PDGFRB—nervous system—schizophrenia	7.82e-05	0.000622	CbGeAlD
Bosutinib—YES1—brain—schizophrenia	7.81e-05	0.00062	CbGeAlD
Bosutinib—STK10—brain—schizophrenia	7.74e-05	0.000615	CbGeAlD
Bosutinib—TAOK3—brain—schizophrenia	7.71e-05	0.000612	CbGeAlD
Bosutinib—PDGFRB—central nervous system—schizophrenia	7.53e-05	0.000599	CbGeAlD
Bosutinib—SRC—brain—schizophrenia	7.51e-05	0.000597	CbGeAlD
Bosutinib—ABL1—endocrine gland—schizophrenia	7.45e-05	0.000592	CbGeAlD
Bosutinib—PDGFRB—cerebellum—schizophrenia	7.36e-05	0.000585	CbGeAlD
Bosutinib—ABCB1—blood plasma—schizophrenia	7.29e-05	0.000579	CbGeAlD
Bosutinib—ABL1—nervous system—schizophrenia	6.97e-05	0.000554	CbGeAlD
Bosutinib—MAP2K5—brain—schizophrenia	6.91e-05	0.000549	CbGeAlD
Bosutinib—CSF1R—brain—schizophrenia	6.74e-05	0.000536	CbGeAlD
Bosutinib—ABL1—central nervous system—schizophrenia	6.71e-05	0.000533	CbGeAlD
Bosutinib—ABL1—cerebellum—schizophrenia	6.56e-05	0.000521	CbGeAlD
Bosutinib—PDGFRB—brain—schizophrenia	5.98e-05	0.000475	CbGeAlD
Bosutinib—ABL1—brain—schizophrenia	5.33e-05	0.000424	CbGeAlD
Bosutinib—ABCB1—forebrain—schizophrenia	3.99e-05	0.000317	CbGeAlD
Bosutinib—CYP3A4—blood—schizophrenia	3.77e-05	0.0003	CbGeAlD
Bosutinib—ABCB1—telencephalon—schizophrenia	3.67e-05	0.000292	CbGeAlD
Bosutinib—CYP3A4—endocrine gland—schizophrenia	3.27e-05	0.00026	CbGeAlD
Bosutinib—ABCB1—gonad—schizophrenia	3.07e-05	0.000244	CbGeAlD
Bosutinib—CYP3A4—nervous system—schizophrenia	3.06e-05	0.000243	CbGeAlD
Bosutinib—CYP3A4—central nervous system—schizophrenia	2.95e-05	0.000234	CbGeAlD
Bosutinib—ABCB1—blood—schizophrenia	2.67e-05	0.000212	CbGeAlD
Bosutinib—ABCB1—midbrain—schizophrenia	2.64e-05	0.00021	CbGeAlD
Bosutinib—ABCB1—endocrine gland—schizophrenia	2.32e-05	0.000184	CbGeAlD
Bosutinib—ABCB1—nervous system—schizophrenia	2.17e-05	0.000172	CbGeAlD
Bosutinib—ABCB1—central nervous system—schizophrenia	2.09e-05	0.000166	CbGeAlD
Bosutinib—ABCB1—cerebellum—schizophrenia	2.04e-05	0.000162	CbGeAlD
Bosutinib—ABCB1—brain—schizophrenia	1.66e-05	0.000132	CbGeAlD
Bosutinib—MAP2K2—Immune System—IL1B—schizophrenia	1.06e-06	6.03e-06	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TP53—schizophrenia	1.06e-06	6.03e-06	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—AKT1—schizophrenia	1.06e-06	6.02e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CACNA1C—schizophrenia	1.06e-06	6.02e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.05e-06	6e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—APOA1—schizophrenia	1.05e-06	5.99e-06	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—AKT1—schizophrenia	1.05e-06	5.98e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOE—schizophrenia	1.05e-06	5.97e-06	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—AKT1—schizophrenia	1.05e-06	5.97e-06	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—AKT1—schizophrenia	1.04e-06	5.96e-06	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—AKT1—schizophrenia	1.04e-06	5.94e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NRG1—schizophrenia	1.04e-06	5.93e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—AKT1—schizophrenia	1.04e-06	5.93e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—GSK3B—schizophrenia	1.04e-06	5.92e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TP53—schizophrenia	1.04e-06	5.92e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TP53—schizophrenia	1.04e-06	5.92e-06	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—AKT1—schizophrenia	1.04e-06	5.91e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	1.03e-06	5.9e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—schizophrenia	1.03e-06	5.9e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL1B—schizophrenia	1.03e-06	5.89e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MEF2C—schizophrenia	1.03e-06	5.88e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PIK3C2A—schizophrenia	1.03e-06	5.87e-06	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—AKT1—schizophrenia	1.02e-06	5.84e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOE—schizophrenia	1.02e-06	5.84e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ESR1—schizophrenia	1.02e-06	5.84e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	1.02e-06	5.82e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOA1—schizophrenia	1.01e-06	5.78e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—EP300—schizophrenia	1.01e-06	5.77e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—AKT1—schizophrenia	1.01e-06	5.76e-06	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—TP53—schizophrenia	1.01e-06	5.76e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL1B—schizophrenia	1.01e-06	5.76e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOE—schizophrenia	1.01e-06	5.75e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL1B—schizophrenia	1.01e-06	5.74e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—S100B—schizophrenia	1.01e-06	5.73e-06	CbGpPWpGaD
Bosutinib—HCK—Immune System—AKT1—schizophrenia	1e-06	5.73e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOE—schizophrenia	1e-06	5.72e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NRG1—schizophrenia	1e-06	5.71e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TP53—schizophrenia	1e-06	5.71e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	9.99e-07	5.7e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—EP300—schizophrenia	9.97e-07	5.69e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOA1—schizophrenia	9.97e-07	5.69e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—GSK3B—schizophrenia	9.96e-07	5.68e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—YWHAZ—schizophrenia	9.96e-07	5.68e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL1B—schizophrenia	9.95e-07	5.67e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MEF2C—schizophrenia	9.93e-07	5.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOA1—schizophrenia	9.92e-07	5.66e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—FOS—schizophrenia	9.9e-07	5.64e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL1B—schizophrenia	9.89e-07	5.64e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—AKT1—schizophrenia	9.83e-07	5.6e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—AKT1—schizophrenia	9.81e-07	5.59e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ESR1—schizophrenia	9.78e-07	5.58e-06	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	9.74e-07	5.56e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ERBB3—schizophrenia	9.74e-07	5.56e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ESR1—schizophrenia	9.63e-07	5.49e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ERBB4—schizophrenia	9.61e-07	5.48e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—EP300—schizophrenia	9.61e-07	5.48e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—YWHAZ—schizophrenia	9.6e-07	5.47e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ESR1—schizophrenia	9.58e-07	5.46e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—AKT1—schizophrenia	9.57e-07	5.46e-06	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—AKT1—schizophrenia	9.46e-07	5.39e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—EP300—schizophrenia	9.45e-07	5.39e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ERBB3—schizophrenia	9.39e-07	5.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCLM—schizophrenia	9.38e-07	5.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TPH1—schizophrenia	9.38e-07	5.35e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—schizophrenia	9.37e-07	5.35e-06	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—AKT1—schizophrenia	9.37e-07	5.34e-06	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—AKT1—schizophrenia	9.33e-07	5.32e-06	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—AKT1—schizophrenia	9.32e-07	5.32e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—GSK3B—schizophrenia	9.29e-07	5.3e-06	CbGpPWpGaD
Bosutinib—HCK—Disease—AKT1—schizophrenia	9.27e-07	5.29e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—EP300—schizophrenia	9.26e-07	5.28e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—EP300—schizophrenia	9.26e-07	5.28e-06	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—AKT1—schizophrenia	9.23e-07	5.26e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—EP300—schizophrenia	9.22e-07	5.26e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP2D6—schizophrenia	9.22e-07	5.26e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SNAP25—schizophrenia	9.22e-07	5.26e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—GSK3B—schizophrenia	9.2e-07	5.24e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	9.19e-07	5.24e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—AKT1—schizophrenia	9.18e-07	5.23e-06	CbGpPWpGaD
Bosutinib—BLK—Immune System—AKT1—schizophrenia	9.1e-07	5.19e-06	CbGpPWpGaD
Bosutinib—FGR—Immune System—AKT1—schizophrenia	9.07e-07	5.17e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	9.06e-07	5.17e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PLA2G4A—schizophrenia	9.04e-07	5.15e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—schizophrenia	9.03e-07	5.15e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—EP300—schizophrenia	9.03e-07	5.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—AKT1—schizophrenia	9.02e-07	5.15e-06	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—AKT1—schizophrenia	9e-07	5.13e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EP300—schizophrenia	8.99e-07	5.13e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—TP53—schizophrenia	8.94e-07	5.1e-06	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—AKT1—schizophrenia	8.92e-07	5.09e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EP300—schizophrenia	8.92e-07	5.09e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—EP300—schizophrenia	8.89e-07	5.07e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—GSK3B—schizophrenia	8.87e-07	5.06e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NRG1—schizophrenia	8.87e-07	5.06e-06	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—AKT1—schizophrenia	8.86e-07	5.05e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EP300—schizophrenia	8.84e-07	5.04e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PRKD1—schizophrenia	8.82e-07	5.03e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MEF2C—schizophrenia	8.79e-07	5.01e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—AKT1—schizophrenia	8.76e-07	5e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—AKT1—schizophrenia	8.76e-07	5e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—GSK3B—schizophrenia	8.74e-07	4.98e-06	CbGpPWpGaD
Bosutinib—ERBB4—Disease—AKT1—schizophrenia	8.73e-07	4.98e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EP300—schizophrenia	8.73e-07	4.98e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOE—schizophrenia	8.72e-07	4.97e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—GSK3B—schizophrenia	8.69e-07	4.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOA1—schizophrenia	8.62e-07	4.91e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—schizophrenia	8.59e-07	4.9e-06	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—AKT1—schizophrenia	8.53e-07	4.87e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EP300—schizophrenia	8.52e-07	4.86e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—YWHAZ—schizophrenia	8.5e-07	4.85e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—AKT1—schizophrenia	8.46e-07	4.82e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOE—schizophrenia	8.4e-07	4.79e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TP53—schizophrenia	8.38e-07	4.78e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP1A2—schizophrenia	8.34e-07	4.76e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—AKT1—schizophrenia	8.34e-07	4.76e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ESR1—schizophrenia	8.32e-07	4.75e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ERBB3—schizophrenia	8.31e-07	4.74e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOA1—schizophrenia	8.3e-07	4.74e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—schizophrenia	8.28e-07	4.72e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—TH—schizophrenia	8.22e-07	4.69e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—EP300—schizophrenia	8.21e-07	4.68e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EP300—schizophrenia	8.17e-07	4.66e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ESR1—schizophrenia	8.02e-07	4.57e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—schizophrenia	8e-07	4.56e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—AKT1—schizophrenia	7.97e-07	4.55e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EP300—schizophrenia	7.94e-07	4.53e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EP300—schizophrenia	7.83e-07	4.47e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—AKT1—schizophrenia	7.7e-07	4.39e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—AKT1—schizophrenia	7.7e-07	4.39e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—EP300—schizophrenia	7.68e-07	4.38e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—AKT1—schizophrenia	7.68e-07	4.38e-06	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—AKT1—schizophrenia	7.65e-07	4.37e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—AKT1—schizophrenia	7.55e-07	4.31e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—GSK3B—schizophrenia	7.55e-07	4.3e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—schizophrenia	7.44e-07	4.24e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EP300—schizophrenia	7.43e-07	4.24e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—AKT1—schizophrenia	7.42e-07	4.23e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—EP300—schizophrenia	7.4e-07	4.22e-06	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—AKT1—schizophrenia	7.38e-07	4.21e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GAPDH—schizophrenia	7.36e-07	4.2e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOA1—schizophrenia	7.35e-07	4.19e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—schizophrenia	7.33e-07	4.18e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—AKT1—schizophrenia	7.32e-07	4.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CLOCK—schizophrenia	7.3e-07	4.16e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—GSK3B—schizophrenia	7.27e-07	4.15e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—schizophrenia	7.24e-07	4.13e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—schizophrenia	7.14e-07	4.07e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNB2—schizophrenia	7.11e-07	4.05e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TPH2—schizophrenia	7.11e-07	4.05e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ESR1—schizophrenia	7.1e-07	4.05e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—EP300—schizophrenia	7.09e-07	4.05e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—AKT1—schizophrenia	7.08e-07	4.04e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DPYD—schizophrenia	6.99e-07	3.99e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EP300—schizophrenia	6.99e-07	3.99e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—COMT—schizophrenia	6.99e-07	3.99e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTP1—schizophrenia	6.96e-07	3.97e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—AKT1—schizophrenia	6.94e-07	3.96e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—schizophrenia	6.94e-07	3.96e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—schizophrenia	6.87e-07	3.92e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—EP300—schizophrenia	6.83e-07	3.9e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—AKT1—schizophrenia	6.8e-07	3.88e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—schizophrenia	6.62e-07	3.78e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—schizophrenia	6.62e-07	3.78e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—EP300—schizophrenia	6.55e-07	3.74e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—AKT1—schizophrenia	6.54e-07	3.73e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—AKT1—schizophrenia	6.53e-07	3.72e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	6.5e-07	3.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—GSK3B—schizophrenia	6.44e-07	3.67e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	6.39e-07	3.65e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—schizophrenia	6.39e-07	3.65e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—schizophrenia	6.38e-07	3.64e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	6.34e-07	3.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—AKT1—schizophrenia	6.25e-07	3.57e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKT1—schizophrenia	6.12e-07	3.49e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EP300—schizophrenia	6.11e-07	3.49e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—EP300—schizophrenia	6.05e-07	3.45e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKT1—schizophrenia	6.03e-07	3.44e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EP300—schizophrenia	5.96e-07	3.4e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—AKT1—schizophrenia	5.85e-07	3.34e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EP300—schizophrenia	5.84e-07	3.33e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKT1—schizophrenia	5.81e-07	3.31e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EP300—schizophrenia	5.75e-07	3.28e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EP300—schizophrenia	5.72e-07	3.26e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—AKT1—schizophrenia	5.71e-07	3.26e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SNAP25—schizophrenia	5.68e-07	3.24e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	5.68e-07	3.24e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—schizophrenia	5.68e-07	3.24e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—schizophrenia	5.65e-07	3.22e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—schizophrenia	5.6e-07	3.2e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKT1—schizophrenia	5.59e-07	3.19e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKT1—schizophrenia	5.59e-07	3.19e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—AKT1—schizophrenia	5.57e-07	3.18e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—AKT1—schizophrenia	5.46e-07	3.11e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—AKT1—schizophrenia	5.43e-07	3.1e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKT1—schizophrenia	5.39e-07	3.07e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—AKT1—schizophrenia	5.37e-07	3.06e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—AKT1—schizophrenia	5.34e-07	3.05e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—schizophrenia	5.32e-07	3.03e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKT1—schizophrenia	5.27e-07	3.01e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—schizophrenia	5.26e-07	3e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOA1—schizophrenia	5.2e-07	2.97e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKT1—schizophrenia	5.15e-07	2.94e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	5.14e-07	2.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AKT1—schizophrenia	5.08e-07	2.9e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TH—schizophrenia	5.07e-07	2.89e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—schizophrenia	5e-07	2.85e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EP300—schizophrenia	4.97e-07	2.83e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—AKT1—schizophrenia	4.96e-07	2.83e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKT1—schizophrenia	4.93e-07	2.81e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKT1—schizophrenia	4.8e-07	2.74e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EP300—schizophrenia	4.79e-07	2.73e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKT1—schizophrenia	4.73e-07	2.7e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—AKT1—schizophrenia	4.64e-07	2.65e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKT1—schizophrenia	4.49e-07	2.56e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—AKT1—schizophrenia	4.47e-07	2.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—schizophrenia	4.37e-07	2.49e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—schizophrenia	4.31e-07	2.46e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTP1—schizophrenia	4.29e-07	2.44e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKT1—schizophrenia	4.29e-07	2.44e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—schizophrenia	4.28e-07	2.44e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—schizophrenia	4.27e-07	2.43e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EP300—schizophrenia	4.24e-07	2.42e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKT1—schizophrenia	4.23e-07	2.41e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—schizophrenia	4.18e-07	2.38e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—AKT1—schizophrenia	4.13e-07	2.36e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—schizophrenia	4.11e-07	2.35e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—schizophrenia	4.09e-07	2.33e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB1—schizophrenia	4.06e-07	2.31e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—AKT1—schizophrenia	3.96e-07	2.26e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.94e-07	2.25e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—schizophrenia	3.94e-07	2.25e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKT1—schizophrenia	3.69e-07	2.11e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—AKT1—schizophrenia	3.66e-07	2.09e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	3.6e-07	2.06e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—schizophrenia	3.55e-07	2.03e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKT1—schizophrenia	3.53e-07	2.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—schizophrenia	3.48e-07	1.99e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKT1—schizophrenia	3.47e-07	1.98e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKT1—schizophrenia	3.46e-07	1.97e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—schizophrenia	3.43e-07	1.95e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—schizophrenia	3.24e-07	1.85e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOA1—schizophrenia	3.2e-07	1.83e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—schizophrenia	3.03e-07	1.73e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKT1—schizophrenia	3e-07	1.71e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—EP300—schizophrenia	3e-07	1.71e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKT1—schizophrenia	2.89e-07	1.65e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT1—schizophrenia	2.56e-07	1.46e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—EP300—schizophrenia	1.85e-07	1.05e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AKT1—schizophrenia	1.81e-07	1.03e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKT1—schizophrenia	1.12e-07	6.37e-07	CbGpPWpGaD
